Juvenile idiopathic arthritis (JIA) is a group of chronic inflammatory joint diseases affecting children under 16 years, causing joint pain, swelling, stiffness (especially morning stiffness lasting more than 30 minutes), and potential long-term joint damage if untreated. Primary management is medical (with pediatric rheumatologist using medications like methotrexate, biologics) to control inflammation and prevent joint destruction. Orthopedic surgeons become involved when medical treatment alone cannot prevent complications: joint contractures (permanent stiffness) requiring soft tissue releases, leg length discrepancies from growth disturbances requiring guided growth surgery, and severe joint destruction in adolescents/young adults requiring joint replacements (hip, knee)—typically in 10-15% of JIA patients who have poorly controlled disease despite modern medications.